Variant position: 194 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 211 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human ERGEYRHWNEWDASQPQLQS VRRIRDQKWHKRGRFPSS
Mouse ERGEFRHWNEWDANQPQLQS VRRIRDQKWHKRGCFLSS
Rat ERGEFRHWNEWDANQPQLQS VRRIRDQKWHKRGCFLSS
Bovine ERGEYRHWNEWDANQPQLQS VRRIRDQKWHKRGVFLSS
Chicken EKGEYRHWNEWDANQPLMQS VRRVRDQQWHQRGSFENS
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
1 – 211 Beta-crystallin B3
2 – 211 Beta-crystallin B3, N-terminally processed
156 – 198 Beta/gamma crystallin 'Greek key' 4
193 – 196
Whole exome sequencing in dominant cataract identifies a new causative factor, CRYBA2, and a variety of novel alleles in known genes.
Reis L.M.; Tyler R.C.; Muheisen S.; Raggio V.; Salviati L.; Han D.P.; Costakos D.; Yonath H.; Hall S.; Power P.; Semina E.V.;
Hum. Genet. 132:761-770(2013)
Cited for: VARIANT CTRCT22 GLU-194;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.